• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human MAGEC3 Polyclonal Antibody

The antibody against MAGEC3 was raised in rabbit using the Recombinant Human Melanoma-associated antigen C3 protein (75-197AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB.

ADC-24487A

The antibody against MAGEC3 was raised in rabbit using the Recombinant Human Melanoma-associated antigen C3 protein (75-197AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, WB.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-24487A ClonalityPolyclonal
Host SpeciesRabbitTarget NameMAGEC3
FormLiquidSpecies ReactivityHuman, Rat
IsotypeIgGStorage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4
Purification Method>95%, Protein G purifiedConjugateNon-conjugated
ApplicationELISA, WBStorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human Melanoma-associated antigen C3 protein (75-197AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ8TD91
Background Information
  • Uniprot Id

    Q8TD91

  • Target Species

    Human

  • Target Name

    MAGEC3

  • Target Full Name

    Melanoma-associated antigen C3

  • Target Synonyms

    MAGEC3; HCA2; Melanoma-associated antigen C3; Cancer/testis antigen 7.2; CT7.2; Hepatocellular carcinoma-associated antigen 2; MAGE-C3 antigen

Inquire Rabbit anti-Human MAGEC3 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification